![Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends | Middle East Medical Portal Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends | Middle East Medical Portal](https://www.middleeastmedicalportal.com/wp-content/uploads/2020/08/422-scaled.jpg)
Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends | Middle East Medical Portal
![Frontiers | Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives Frontiers | Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives](https://www.frontiersin.org/files/Articles/320618/fendo-09-00253-HTML-r1/image_m/fendo-09-00253-g001.jpg)
Frontiers | Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives
![Endocrines | Free Full-Text | Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options Endocrines | Free Full-Text | Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options](https://www.mdpi.com/endocrines/endocrines-02-00043/article_deploy/html/images/endocrines-02-00043-g001.png)
Endocrines | Free Full-Text | Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options
![A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-018-4728-6/MediaObjects/125_2018_4728_Fig1_HTML.png)
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink
![The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY) | Clinical Diabetes and Endocrinology | Full Text The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY) | Clinical Diabetes and Endocrinology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40842-020-00112-5/MediaObjects/40842_2020_112_Fig1_HTML.png)